[go: up one dir, main page]

NO20021827L - Direkte kompresjons-polymer tablettkjerne - Google Patents

Direkte kompresjons-polymer tablettkjerne

Info

Publication number
NO20021827L
NO20021827L NO20021827A NO20021827A NO20021827L NO 20021827 L NO20021827 L NO 20021827L NO 20021827 A NO20021827 A NO 20021827A NO 20021827 A NO20021827 A NO 20021827A NO 20021827 L NO20021827 L NO 20021827L
Authority
NO
Norway
Prior art keywords
tablet core
aliphatic amine
amine polymer
direct compression
approx
Prior art date
Application number
NO20021827A
Other languages
English (en)
Other versions
NO20021827D0 (no
Inventor
Joseph Tyler
John S Petersen
Original Assignee
Geltex Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltex Pharma Inc filed Critical Geltex Pharma Inc
Publication of NO20021827D0 publication Critical patent/NO20021827D0/no
Publication of NO20021827L publication Critical patent/NO20021827L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Det beskrives en tablettkjerne som omfatter minst ca. 95 vekt% av en alifatisk aminpolymer. Det beskrives også en fremgangsmåte for fremstilling av en tablett- kjerne som omfatter minst ca. 95 vekt% av en alifatisk aminpolymerharpiks. Frem- gangsmåten omfatter det trinn å presse den alifatiske aminpolymer slik at tablett- kjernen dannes. Tablettkjemen kan videre innbefatte ett eller flere hjelpestoffer. Denne fremgangsmåte for fremstilling av tablettkjemen omfatter trinnene: (1) hydratisering av den alifatiske aminpolymer til det ønskede fuktighetsnivå; (2) blanding av den alifatiske aminpolymer med hjelpestoffene i slike mengder at polymeren omfatter minst ca. 95 vekt% av den resulterende blanding; og (3) pressing av blandingen for å danne tablettkjemen. Det beskrives videre en drasjert tablett som omfatter en alifatisk aminpolymerkjeme, hvor drasjeringen er en vann- basert drasjering.
NO20021827A 1999-10-19 2002-04-18 Direkte kompresjons-polymer tablettkjerne NO20021827L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16025899P 1999-10-19 1999-10-19
US17422700P 2000-01-03 2000-01-03
PCT/US2000/028548 WO2001028527A2 (en) 1999-10-19 2000-10-13 Direct compression polymer tablet core

Publications (2)

Publication Number Publication Date
NO20021827D0 NO20021827D0 (no) 2002-04-18
NO20021827L true NO20021827L (no) 2002-05-29

Family

ID=26856737

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021827A NO20021827L (no) 1999-10-19 2002-04-18 Direkte kompresjons-polymer tablettkjerne

Country Status (29)

Country Link
EP (1) EP1239837B1 (no)
JP (4) JP4942271B2 (no)
KR (1) KR100794427B1 (no)
CN (1) CN1202812C (no)
AR (1) AR026067A1 (no)
AT (1) ATE286386T1 (no)
AU (1) AU778262B2 (no)
BG (1) BG106626A (no)
BR (1) BRPI0015061B8 (no)
CA (1) CA2387915C (no)
CZ (1) CZ20021344A3 (no)
DE (1) DE60017285T2 (no)
EA (1) EA200200387A1 (no)
EE (1) EE200200209A (no)
ES (1) ES2235969T3 (no)
HK (1) HK1049451B (no)
HU (1) HUP0203334A2 (no)
IL (1) IL149146A0 (no)
IS (1) IS6343A (no)
MX (1) MXPA02003684A (no)
MY (1) MY125495A (no)
NO (1) NO20021827L (no)
NZ (1) NZ518334A (no)
PL (1) PL364888A1 (no)
PT (1) PT1239837E (no)
SK (1) SK5412002A3 (no)
TR (1) TR200201087T2 (no)
TW (1) TWI225413B (no)
WO (1) WO2001028527A2 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001028527A2 (en) * 1999-10-19 2001-04-26 Geltex Pharmaceuticals, Inc. Direct compression polymer tablet core
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7767768B2 (en) 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
US7608674B2 (en) 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7449605B2 (en) 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
JP2007517047A (ja) * 2003-12-31 2007-06-28 ジェンザイム・コーポレーション 腸溶コーティングされた脂肪族アミンポリマーの胆汁酸捕捉因子
KR101223335B1 (ko) 2004-03-30 2013-01-17 리립사, 인크. 이온 결합 조성물
US7985418B2 (en) * 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
AU2012200480B2 (en) * 2004-11-01 2014-10-16 Genzyme Corporation "Aliphatic amine polymer salts for tableting"
MX2007011153A (es) * 2005-03-17 2007-12-12 Amgen Inc Metodos para reducir la calcificacion.
EP1951266A2 (en) 2005-09-02 2008-08-06 Genzyme Corporation Method for removing phosphate and polymer used therefore
CN101272762B (zh) * 2005-09-15 2013-02-06 基酶有限公司 胺聚合物的小袋制剂
EP2441779A1 (en) * 2006-09-01 2012-04-18 USV Limited Process for the preparation of sevelamer hydrochloride and formulation thereof
JP2010504975A (ja) 2006-09-29 2010-02-18 ゲンズイメ コーポレーション アミドデンドリマー組成物
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
WO2009034540A1 (en) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Pharmaceutical composition of sevelamer
DE102008030046A1 (de) * 2008-06-25 2009-12-31 Ratiopharm Gmbh Kompaktiertes Polyallylamin-Polymer
WO2010041268A2 (en) 2008-09-02 2010-04-15 Usv Limited Crosslinked polymers
US20100330175A1 (en) * 2009-06-24 2010-12-30 Jobdevairakkam Christopher N Cross-linked polyallylamine tablet core
WO2010149794A2 (en) * 2009-06-26 2010-12-29 Combino Pharm, S.L. Novel pharmaceutical composition comprising poly (allylamin-co-n,n'-diallyl- 1,3-diamino-2-hydroxypropane)
ES2350999B1 (es) * 2009-06-26 2011-12-07 Combino Pharm, S.L. Nueva composición farmacéutica comprendiendo hidrocloruro de poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxi propano).
US20120219626A1 (en) * 2009-10-22 2012-08-30 Niels Jaap Osinga Pharmaceutical Compositions of Sevelamer
EP2545907A1 (en) 2011-07-15 2013-01-16 Combino Pharm, S.L. Aqueous wet granulation process for cross-linked polyallylamine polymers
JP6289367B2 (ja) * 2012-06-05 2018-03-07 武田薬品工業株式会社 有核錠
CN102908325B (zh) * 2012-11-12 2014-07-30 南京生命能科技开发有限公司 一种碳酸司维拉姆药用片剂组合物及其制备方法
CN107412166B (zh) * 2017-08-08 2020-03-24 同济大学 一种纳米复合吸附磷材料及其制备与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2108090C1 (ru) * 1991-07-03 1998-04-10 Дзе Апджон Компани Таблетка, содержащая гидрохлорид колестипола, и способ ее получения
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
JP3389493B2 (ja) * 1997-04-04 2003-03-24 中外製薬株式会社 リン酸結合性ポリマー製剤
TW592727B (en) * 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
WO2001028527A2 (en) * 1999-10-19 2001-04-26 Geltex Pharmaceuticals, Inc. Direct compression polymer tablet core

Also Published As

Publication number Publication date
MXPA02003684A (es) 2002-08-30
CN1202812C (zh) 2005-05-25
CA2387915C (en) 2007-04-17
CA2387915A1 (en) 2001-04-26
PL364888A1 (en) 2004-12-27
HK1049451A1 (en) 2003-05-16
KR100794427B1 (ko) 2008-01-16
JP4942271B2 (ja) 2012-05-30
CZ20021344A3 (cs) 2002-08-14
AU778262B2 (en) 2004-11-25
IS6343A (is) 2002-04-15
CN1382041A (zh) 2002-11-27
IL149146A0 (en) 2002-11-10
JP2014065749A (ja) 2014-04-17
BRPI0015061B8 (pt) 2021-05-25
WO2001028527A3 (en) 2002-01-03
EE200200209A (et) 2003-06-16
BR0015061A (pt) 2002-07-23
EP1239837B1 (en) 2005-01-05
NZ518334A (en) 2003-08-29
HUP0203334A2 (hu) 2003-02-28
SK5412002A3 (en) 2002-09-10
BRPI0015061B1 (pt) 2016-03-22
HK1049451B (zh) 2005-12-16
KR20020059629A (ko) 2002-07-13
ATE286386T1 (de) 2005-01-15
DE60017285T2 (de) 2005-12-08
MY125495A (en) 2006-08-30
EP1239837A2 (en) 2002-09-18
BG106626A (bg) 2003-03-31
AR026067A1 (es) 2002-12-26
TR200201087T2 (tr) 2002-08-21
TWI225413B (en) 2004-12-21
ES2235969T3 (es) 2005-07-16
JP2003512317A (ja) 2003-04-02
JP5903111B2 (ja) 2016-04-13
DE60017285D1 (de) 2005-02-10
AU1088701A (en) 2001-04-30
NO20021827D0 (no) 2002-04-18
EA200200387A1 (ru) 2002-10-31
JP5583110B2 (ja) 2014-09-03
PT1239837E (pt) 2005-05-31
JP2016000753A (ja) 2016-01-07
WO2001028527A2 (en) 2001-04-26
JP2012067132A (ja) 2012-04-05

Similar Documents

Publication Publication Date Title
NO20021827L (no) Direkte kompresjons-polymer tablettkjerne
DK0862418T3 (da) Fremgangsmåde til fremstilling af morphologisk ensartede mikrokapsler såvel som mikrokapsler fremstillet efter denne fremgangsmåde
DE69721489D1 (de) Herstellungsverfahren von löslichen verabreichungssystemen unter verwendung von flüchtigen salzen
CA2382523A1 (en) Method of optimizing parameter values in a process of producing a product
EP0731448A3 (en) Frame erasure compensation techniques
NO972608L (no) Opplösningshjelpemidler for hydrofile makromolekyler
YU46797B (sh) Postupak za dobijanje ojačanog poliuretanskog polimera
AU2001236905A1 (en) Bioadhesive composition
DK0791037T3 (da) Fremgangsmåde til stabilisering af gelatineprodukter
NO964213D0 (no) Forbedret anti-flass shampo
AU6358594A (en) Macromolecular microparticles and methods of production
AU5651686A (en) Process for preparing polymeric particles
ATE37982T1 (de) N-acetyl-p-aminophenol-mittel enthaltend teilweise gelierte staerke sowie verfahren zu deren herstellung.
DK1158962T3 (da) Fremgangsmåde til fremstilling af faste cyclodextrinholdige doseringsformer
EP0404184A3 (en) Process for the preparation of microvoid-containing polymer particles
ATE149826T1 (de) Verfahren zur herstellung von festen pharmazeutischen retardformen
DE69616072D1 (de) Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung
KR850001693A (ko) 아모술랄롤 하이드로클로라이드 지속성 제제의 제조방법
DK0749305T3 (da) Fremgangsmåde til fremstilling af avermectin/zein-sammensætninger
NO954858L (no) Fremgangsmåte for fremstilling av en biodegraderbar, hydrofobisk og transparent film og film oppnådd ved fremgangsmåten
ATE220701T1 (de) Verfahren zur herstellung von reaktiven pulverlackzusammensetzungen
AU2926800A (en) Process for the preparation of a diol
ATE437190T1 (de) Polymerisationsverfahren zur herstellung von syndiotaktischem 1,2-polybutadien
AU8403298A (en) Nucleic acid ladders
ES2104363T3 (es) Proceso para la preparacion de acido aminometanofosfonico.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application